Chemours Co

Previous wording

The following table sets forth our results of operations for the three and six months ended June 30, 2026 and 2025.

Current wording

The following table sets forth our results of operations for the three and nine months ended September 30, 2026 and 2025.

Previous wording

Our net sales were relatively flat at $1.6 billion for the three months ended June 30, 2026 and 2025, as a decrease in volume of 4% was offset by an increase in price of 2% and favorable currency movements of 1%. The decrease in volume was primarily driven by lower volumes in Thermal & Specialized Solutions ("TSS") and Advanced Performance Materials ("APM") segments, while the increase in price was attributable to our TSS and Titanium Technologies ("TT") segments.

Current wording

Our net sales increased by $45 million (or 3%) to $1.5 billion for the three months ended September 30, 2026, compared with net sales of $1.5 billion for the same period in 2025. The increase in our net sales for the three months ended September 30, 2026 was primarily attributable to an increase in price of 5%, partially offset by a decrease in volume of 2%. The decrease in volume was primarily driven by lower volumes in our Thermal & Specialized Solutions ("TSS") segment, while the increase in price was attributable to our Advanced Performance Materials ("APM") and Titanium Technologies ("TT") segments.

Previous wording

Our net sales were relatively flat at $3 billion for the six months ended June 30, 2026 and 2025, as a 4% decrease in volume was offset by a 2% increase in price and favorable currency movements adding a 2% tailwind to the segment’s net sales as compared to the same period in the prior year. The decrease in volume was primarily driven by lower volumes in our APM and TT segment, while the increase in price was attributable to our TSS segment.

Current wording

Our net sales were relatively flat at $4.5 billion for the nine months ended September 30, 2026 and 2025, as a 3% decrease in volume was offset by a 3% increase in price and favorable currency movements adding a 1% tailwind to the segment’s net sales as compared to the same period in the prior year. The decrease in volume was primarily driven by lower volumes in our APM segment, while the increase in price was primarily attributable to our TSS segment.

Previous wording

Our selling, general, and administrative (“SG&A”) expense increased by $45 million (or 11%) and $69 million (or 13%) to $469 million and $616 million for the three and six months ended June 30, 2026, respectively, compared with SG&A expense of $424 million and $547 million for the same periods in 2025. The increase in our SG&A expense for the three months ended June 30, 2026 was primarily attributable to an increase of approximately $120 million related to adjustments to environmental reserves, as well as a decrease of approximately $10 million in the MOU benefit related to litigation costs. This was partially offset by lower corporate litigation related charges and legacy legal fees in the period of approximately $90 million. The increase in our SG&A expense for the six months ended June 30, 2026 was primarily attributable to an increase of approximately $120 million related to adjustments to environmental reserves, and a decrease of approximately $20 million in the MOU benefit related to litigation costs. This was partially offset by lower corporate litigation related charges and legacy legal fees in the period of approximately $60 million.

Current wording

The decrease in our SG&A expense for the nine months ended September 30, 2026 was primarily attributable to lower corporate litigation related charges, inclusive of the above mentioned PFAS Insurance MOU, and legacy legal fees in the period of $212 million. This was partially offset by an increase of $102 million related to adjustments to environmental reserves and a decrease of $24 million in the MOU benefit related to litigation costs.

Previous wording

Our research and development (“R&D”) expense was largely unchanged at $27 million and $53 million for the three and six months ended June 30, 2026, respectively, compared with R&D expense of $28 million and $55 million for the same periods in 2025.

Current wording

Our research and development (“R&D”) expense was largely unchanged at $24 million and $77 million for the three and nine months ended September 30, 2026, respectively, compared with R&D expense of $26 million and $81 million for the same periods in 2025.

Previous wording

Our restructuring, asset-related, and other charges decreased by $15 million (or 83%) and $35 million (or 69%) to $3 million and $16 million for the three and six months ended June 30, 2026, respectively, compared with restructuring, asset-related, and other charges of $18 million and $51 million for the same periods in 2025. Our restructuring, asset-related, and other charges for the three and six months ended June 30, 2026 were attributable to $2 million and $6 million, respectively, of charges related to our decision to exit our SPS Capstone TMbusiness, along with $1 million and $1 million, respectively, of decommissioning and other charges related to the Titanium Technologies Transformation Program. Additionally, for the six months ended June 30, 2026, our restructuring, asset-related, and other charges were attributable to employee separation charges of $9 million related to the 2026 Restructuring Program. Our restructuring, asset-related, and other charges for the three and six months ended June 30, 2025 were primarily attributable to $17 million and $45 million, respectively, of charges related to our decision to exit our SPS Capstone TM business, along with $1 million and $5 million, respectively, of decommissioning and other charges related to the Titanium Technologies Transformation Program.

Current wording

Our restructuring, asset-related, and other charges decreased by $1 million (or 25%) and $36 million (or 65%) to $3 million and $19 million for the three and nine months ended September 30, 2026, respectively, compared with restructuring, asset-related, and other charges of $4 million and $55 million for the same periods in 2025. Our restructuring, asset-related, and other charges for the three and nine months ended September 30, 2026 were attributable to $2 million and $8 million, respectively, of charges related to our decision to exit our SPS Capstone TMbusiness, along with employee separation charges of $1 million and $10 million, respectively, related to the 2026 Restructuring Program. Additionally, for the nine months ended September 30, 2026, we recorded $1 million of decommissioning and other charges related to the Titanium Technologies Transformation Program.

Previous wording

Our equity in earnings of affiliates was flat at $9 million and $17 million for the three and six months ended June 30, 2026, respectively, compared with equity in earnings of affiliates of $9 million and $17 million for the same periods in 2025.

Current wording

Our equity in earnings of affiliates was relatively flat at $11 million and $28 million for the three and nine months ended September 30, 2026, respectively, compared with equity in earnings of affiliates of $9 million and $27 million for the same periods in 2025.

Previous wording

Our interest expense, net increased by $1 million (or 1%) and $4 million (or 3%) to $68 million and $137 million for the three and six months ended June 30, 2026, respectively, compared with interest expense, net of $67 million and $133 million for the same periods in 2025. The increase in our interest expense, net was primarily attributable to higher interest rates on our variable rate debt following the amendment to the Amended and Restated Credit Agreement related to the 2032 U.S. Dollar Term Loan in October 2025 and higher interest rates on the issuance of the 2034 Notes in March 2026.

Current wording

Our interest expense, net increased by $1 million (or 1%) and $5 million (or 2%) to $69 million and $206 million for the three and nine months ended September 30, 2026, respectively, compared with interest expense, net of $68 million and $201 million for the same periods in 2025. The increase in our interest expense, net was primarily attributable to higher interest rates on our variable rate debt following the amendment to the Amended and Restated Credit Agreement related to the 2032 U.S. Dollar Term Loan in October 2025 and higher interest rates on the issuance of the 2034 Notes in March 2026, partially offset by the pay down of the Senior Secured Euro Term Loan.

Previous wording

For the three and six months ended June 30, 2026, we recognized a loss on extinguishment of debt of $2 million and $11 million, respectively, related to the partial early redemption of the senior secured Euro term loan due August 2028, along with costs associated with early redemption of the senior unsecured notes due May 2027 and partial early redemption of the senior unsecured notes due November 2028, respectively. See "Note 15 - Debt" to the Interim Consolidated Financial Statements for further details.

Current wording

For the nine months ended September 30, 2026, we recognized a loss on extinguishment of debt of $11 million related to the partial early redemptions of the senior secured Euro term loan due August 2028, along with costs associated with early redemption of the senior unsecured notes due May 2027 and partial early redemption of the senior unsecured notes due November 2028. See "Note 15 - Debt" to the Interim Consolidated Financial Statements for further details.

Previous wording

Our other income, net increased by $271 million (or over 100%) and $290 million (or over 100%) to $273 million and $296 million for the three and six months ended June 30, 2026, respectively, compared with other income, net of $2 million and $6 million for the same periods in 2025. The increase in our other income, net was primarily attributable to the gain on sale of nine parcels of land sold in Kuan Yin, Taiwan in the second quarter of 2026. See "Note 10 - Property, Plant, and Equipment, Net" related to the to the Interim Consolidated Financial Statements for further details.

Current wording

Our other income, net increased by $35 million (or over 100%) and $324 million (or over 100%) to $51 million and $347 million for the three and nine months ended September 30, 2026, respectively, compared with other income, net of $16 million and $23 million for the same periods in 2025. The increase in our other income, net was attributable to the gain on sale of ten parcels of land sold in Kuan Yin, Taiwan in the second and third quarters of 2026. See "Note 10 - Property, Plant, and Equipment, Net" to the Interim Consolidated Financial Statements for further details.

Previous wording

There was a $142 million increase in our provision for income taxes for the three months ended June 30, 2026 as compared to the three months ended June 30, 2025. Our provision for income taxes for the three months ended June 30, 2026 was primarily attributable to the geographical mix of earnings and the recognition of a full valuation allowance against our U.S. federal and state deferred tax assets, inclusive of approximately $208 million related to prior year deferred tax assets, as a result of matters discussed in "Note 17 - Commitments and Contingent Liabilities". Additionally, our provision for income taxes was impacted by profit in inventory, withholding taxes on the repatriation of earnings, the non-taxable gain on the Company’s sale of land for local Taiwanese tax purposes, and a foreign derived deduction eligible income tax benefit resulting from tax law changes pursuant to the 2025 Tax Act. Our provision for the three months ended June 30, 2025 was primarily attributable to $169 million tax expense to record a valuation allowance against our deferred tax asset for U.S. federal and state interest carryforwards, as well as $9 million tax expense to record valuation allowances against certain U.S. state and foreign net operating loss carryforwards. These were partially offset by a $66 million tax benefit related to environmental and litigation reserve, both recorded during the quarter.

Current wording

We recognized a provision for income taxes of $26 million and a benefit from income taxes of $8 million for the three months ended September 30, 2026 and 2025, respectively. The $34 million increase in our provision for income taxes for the three months ended September 30, 2026 as compared to the three months ended September 30, 2025 was due to several factors. Our provision for income taxes for the three months ended September 30, 2026 was primarily attributable to the geographical mix of earnings, adjustments related to our U.S. federal, state, and foreign valuation allowances, withholding taxes on the repatriation of earnings, and the non-taxable gain on the Company’s sale of land for local Taiwanese tax purposes. These were offset by profit in inventory and a foreign derived deduction eligible income tax benefit resulting from tax law changes pursuant to the Tax Act.

Previous wording

We operate through three principal reportable segments, which were organized based on their similar economic characteristics, the nature of products and production processes, end-use markets, channels of distribution, and regulatory environments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Other Non-Reportable Segment includes the Company’s Performance Chemicals and Intermediates business.

Current wording

We operate through three principal reportable segments, which were organized based on their similar economic characteristics, the nature of products and production processes, end-use markets, channels of distribution, and regulatory environments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Other Non-Reportable Segment includes the Company’s Performance Chemicals and Intermediates business.

Previous wording

non-operating pension and other post-retirement employee benefit costs, which represents the non-service cost component of net periodic pension (income) costs;

Current wording

non-operating pension and other post-retirement employee benefit costs, which represent the non-service cost component of net periodic pension (income) costs;

Previous wording

A reconciliation of Segment Adjusted EBITDA to our consolidated income (loss) before income taxes for the three and six months ended June 30, 2026 and 2025 is included in “Note 23 – Segment Information” to the Interim Consolidated Financial Statements.

Current wording

A reconciliation of Segment Adjusted EBITDA to our consolidated income (loss) before income taxes for the three and nine months ended September 30, 2026 and 2025 is included in “Note 23 – Segment Information” to the Interim Consolidated Financial Statements.

Previous wording

The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Thermal & Specialized Solutions segment for the three and six months ended June 30, 2026 and 2025.

Current wording

The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Thermal & Specialized Solutions segment for the three and nine months ended September 30, 2026 and 2025.

Previous wording

Our Thermal & Specialized Solutions segment’s net sales decreased by $6 million (or 1%) to $591 million for the three months ended June 30, 2026, compared with segment net sales of $597 million for the same period in 2025. The decrease in segment net sales for the three months ended June 30, 2026 was primarily attributable to a 4% decrease in volume, partially offset by a 2% increase in price and favorable currency movements adding a 1% tailwind to the segment’s net sales. The decrease in volumes was primarily attributable to lower stationary AC aftermarket refrigerant sales of TSS Opteon™ blends in North America, compared with elevated demand in the second quarter of 2025 driven by the stationary technology transition under the U.S. AIM Act, partially offset by higher Freon™ prices, primarily in the automotive segment.

Current wording

Our Thermal & Specialized Solutions segment’s net sales increased by $47 million (or 3%) to $1.7 billion for the nine months ended September 30, 2026, compared with segment net sales of $1.6 billion for the same period in 2025. The increase in segment net sales for the nine months ended September 30, 2026 was primarily attributable to an increase in prices of 4% and favorable currency movements adding a 1% tailwind to the segment’s net sales as compared to the same period in the prior year, partially offset by a decrease in volumes of 2%. The increase in price was primarily attributable to higher Freon™ sales in the automotive aftermarket, while the decrease in volume was primarily attributable to lower stationary AC aftermarket refrigerant sales of TSS Opteon™ blends in North America, compared with elevated demand in the prior year driven by the stationary technology transition under the U.S. AIM Act, partially offset by higher Freon™ prices, primarily in the automotive segment.

Previous wording

The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Titanium Technologies segment for the three and six months ended June 30, 2026 and 2025.

Current wording

The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Titanium Technologies segment for the three and nine months ended September 30, 2026 and 2025.

Previous wording

For the three months ended June 30, 2026, segment Adjusted EBITDA increased by $6 million (or 3%) to $213 million and Adjusted EBITDA margin increased by approximately 100 basis points to 36%, compared with segment Adjusted EBITDA of $207 million and Adjusted EBITDA margin of 35% for the same period in 2025. The increase in segment Adjusted EBITDA and Adjusted EBITDA margin for the three months ended June 30, 2026 was primarily attributable to the aforementioned increase in refrigerant prices, as well as cost timing favorability.

Current wording

For the nine months ended September 30, 2026, segment Adjusted EBITDA increased by $30 million (or 25%) to $152 million and Adjusted EBITDA margin increased by approximately 100 basis points to 8%, compared with segment Adjusted EBITDA of $122 million and Adjusted EBITDA margin of 7% for the same period in 2025. The increases in segment Adjusted EBITDA and Adjusted EBITDA margin for the nine months ended September 30, 2026 were primarily attributable to the aforementioned increase in prices.

Previous wording

The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Advanced Performance Materials segment for the three and six months ended June 30, 2026 and 2025.

Current wording

The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Advanced Performance Materials segment for the three and nine months ended September 30, 2026 and 2025.

Previous wording

Our Advanced Performance Materials segment’s net sales decreased by $70 million (or 11%) to $569 million for the six months ended June 30, 2026, compared with segment net sales of $639 million for the same period in 2025. The decrease in segment net sales for the six months ended June 30, 2026 was primarily attributable to a 14% decrease in volume, partially offset by a 1% increase in price and favorable currency movements adding a 2% tailwind to the segment’s net sales in the same period of the prior year. Volumes decreased primarily due to operational impacts in the first quarter of 2026 related to the previously disclosed and resolved outage at the Washington Works site, as well as operational impacts to the SPS Capstone TM product line, partially offset by beginning signs of recovery in semiconductors and aerospace, as well as growth in electric vehicles and data centers.

Current wording

Our Advanced Performance Materials segment’s net sales decreased by $45 million (or 5%) to $906 million for the nine months ended September 30, 2026, compared with segment net sales of $951 million for the same period in 2025. The decrease in segment net sales for the nine months ended September 30, 2026 was primarily attributable to an 8% decrease in volume, partially offset by a 2% increase in price and favorable currency movements adding a 1% tailwind to the segment’s net sales compared with the same period of the prior year. Volumes decreased primarily due to the exit of the SPS Capstone TM product line, partially offset by growth in semiconductors, aerospace, electric vehicles and data centers.

Previous wording

In addition to our reportable segments, we assign certain costs to “Corporate expenses”, which is presented separately in the segment reconciliation table below and in “Note 23 – Segment Information” to the Interim Consolidated Financial Statements. Corporate expenses include certain legacy-related legal and environmental expenses, stock-based compensation expenses and other corporate costs, but excludes segment unallocated items (described below).

Current wording

In addition to our reportable segments, we assign certain costs to “Corporate expenses”, which is presented separately in the segment reconciliation table below and in “Note 23 – Segment Information” to the Interim Consolidated Financial Statements. Corporate expenses include certain legacy-related legal and environmental expenses, stock-based compensation expenses and other corporate costs, but exclude segment unallocated items (described below).

Previous wording

Corporate and Other costs decreased by $4 million (or 9%) and $13 million (or 13%) to $42 million and $90 million for the three and six months ended June 30, 2026, compared with Corporate and Other costs of $46 million and $103 million for the same periods in 2025. The decrease in Corporate and Other costs for the three and six months ended June 30, 2026 was primarily attributable to lower environmental and PFOA reserve adjustments in the second quarter of 2026, lower legacy legal costs, decreased proxy costs and a decrease in other corporate expenses due to prior year adjustments, partially offset by a decrease in the MOU benefit and an increase in executive office spend.

Current wording

Corporate and Other costs were largely unchanged at $46 million for the three months ended September 30, 2026, compared with Corporate and Other costs of $45 million for the same period in 2025. Additionally, Corporate and Other costs decreased by $12 million (or 8%) to $136 million for the nine months ended September 30, 2026, compared with Corporate and Other costs of $148 million for the same period in 2025. The decrease in Corporate and Other costs for the nine months ended September 30, 2026 was primarily attributable to lower legacy legal spend and lower environmental reserve accruals in 2026, partially offset by a decrease in the MOU benefit.

Previous wording

The following table sets forth our corporate and unallocated items for the three and six months ended June 30, 2026 and 2025.

Current wording

The following table sets forth our corporate and unallocated items for the three and nine months ended September 30, 2026 and 2025.

Previous wording

For the three and six months ended June 30, 2026, loss on extinguishments of debt includes $2 million and $11 million, respectively, related to the partial early redemption of the senior secured Euro term loan due August 2028, along with costs associated with early redemption of the senior unsecured notes due May 2027 and partial early redemption of the senior unsecured notes due November 2028, which is discussed in further detail in "Note 15 - Debt"

Current wording

For the nine months ended September 30, 2026, loss on extinguishment of debt includes $11 million related to the partial early redemptions of the senior secured Euro term loan due August 2028, along with costs associated with early redemption of the senior unsecured notes due May 2027 and partial early redemption of the senior unsecured notes due November 2028, which is discussed in further detail in "Note 15 - Debt".

Previous wording

For three and six months ended June 30, 2026, Gain on sales of assets and businesses, net, includes a $266 million gain on sale of assets related to the sale of nine parcels of land in Kuan Yin, Taiwan. Refer to “Note 10 – Property, Plant and Equipment" for further details.

Current wording

For three and nine months ended September 30, 2026, Gain on sales of assets and businesses, net, includes a $50 million and $316 million gain, respectively, on sale of assets related to the sale of ten parcels of land in Kuan Yin, Taiwan. Refer to “Note 10 – Property, Plant and Equipment" for further details.

Previous wording

For the three and six months ended June 30, 2026, Litigation-related charges includes $223 million and $235 million related to PFOA and PFAS legal reserves. Refer to “Note 17 – Commitments and Contingent Liabilities" for further details.

Current wording

For the three and nine months ended September 30, 2026, Litigation-related income (charges), net, includes $138 million of income and $96 million of charges related to PFOA and PFAS legal reserves and related cost sharing, including $150 million received by the Company related to the PFAS Insurance MOU. Refer to “Note 17 – Commitments and Contingent Liabilities" for further details.

Previous wording

For both the three and six months ended June 30, 2026, Environmental charges includes $141 million related to expanded off-site drinking water program requirements at Washington Works and Chambers Works pursuant to the 2026 Consent Decree, as well as the impact of the 2026 Consent Decree on other long-term OM&M projects at Washington Works. Refer to “Note 17 – Commitments and Contingent Liabilities" for further details.

Current wording

For nine months ended September 30, 2026, Environmental charges include $136 million related to expanded off-site drinking water program requirements at Washington Works and Chambers Works pursuant to the 2026 Consent Decree, as well as the impact of the 2026 Consent Decree on other long-term OM&M projects at Washington Works. Refer to “Note 17 – Commitments and Contingent Liabilities" for further details.

Previous wording

At June 30, 2026, we had total unrestricted cash and cash equivalents of $671 million, of which $516 million was held by our foreign subsidiaries. The availability under our Revolving Credit Facility as of June 30, 2026 was $953 million, net of $47 million in outstanding letters of credit, and is subject to compliance with certain covenants, including those related to the last twelve months of our consolidated earnings before interest, taxes, depreciation, and amortization ("EBITDA") and senior secured net debt, both of which are defined under the Credit Agreement. At June 30, 2026, we were in compliance with the applicable covenants under the Credit Agreement. Our revolving commitments are comprised of $780 million in revolving commitments that mature on May 2, 2030 and $220 million in revolving commitments that mature on October 7, 2026; in each case, subject to springing maturity provisions. Our debt financing arrangements are described in further detail in “Note 20 – Debt” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025.

Current wording

At September 30, 2026, we had total unrestricted cash and cash equivalents of $698 million, of which $410 million was held by our foreign subsidiaries. The availability under our Revolving Credit Facility as of September 30, 2026 was $953 million, net of $47 million in outstanding letters of credit, and is subject to compliance with certain covenants, including those related to the last twelve months of our consolidated earnings before interest, taxes, depreciation, and amortization ("EBITDA") and senior secured net debt, both of which are defined under the Credit Agreement. At September 30, 2026, we were in compliance with the applicable covenants under the Credit Agreement. Our revolving commitments are comprised of $780 million in revolving commitments that mature on May 2, 2030 and $220 million in revolving commitments that matured on October 7, 2026; in each case, subject to springing maturity provisions. Our debt financing arrangements are described in further detail in “Note 20 – Debt” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025.

Previous wording

Throughout the year, we utilize supply chain financing arrangements with several third-party financial institutions to manage our working capital needs and enhance liquidity. We also participate in certain customers’ supply chain financing and other early pay programs as a routine source of working capital. During the three months ended June 30, 2026 and 2025, we utilized various customer facilitated supply chain financing facilities to accelerate the collection of $89 million and $133 million, respectively, of our accounts receivable, incurring an immaterial discount amount for both periods. For the six months ended June 30, 2026 and 2025, we accelerated the collection of approximately $156 million and $226 million, respectively, of our accounts receivable, incurring an immaterial discount amount of both periods. See “Note 8 – Accounts and Notes Receivable, Net” to the Interim Consolidated Financial Statementsfor further details regarding our supplier financing programs.

Current wording

Throughout the year, we utilize supply chain financing arrangements with several third-party financial institutions to manage our working capital needs and enhance liquidity. We also participate in certain customers’ supply chain financing and other early pay programs as a routine source of working capital. During the three months ended September 30, 2026 and 2025, we utilized various customer facilitated supply chain financing facilities to accelerate the collection of $102 million and $39 million, respectively, of our accounts receivable, incurring an immaterial discount amount for both periods. For the nine months ended September 30, 2026 and 2025, we accelerated the collection of $258 million and $265 million, respectively, of our accounts receivable, incurring an immaterial discount amount for both periods. See “Note 8 – Accounts and Notes Receivable, Net” to the Interim Consolidated Financial Statementsfor further details regarding our supplier financing programs.

Previous wording

In the second quarter of 2026, the Company used €230 million of cash to pay down a portion of the outstanding tranche B-3 euro term loan due August 2028.

Current wording

For the three and nine months ended September 30, 2026, the Company used €50 million (approximately $58 million) and €280 million (approximately $324 million) of cash, respectively, to pay down a portion of the outstanding tranche B-3 euro term loan due August 2028.

Previous wording

For the three and six months ended June 30, 2026, we recognized a loss on extinguishments of debt of $2 million and $11 million, respectively, related to the partial early redemption of the senior secured Euro term loan due August 2028, along with costs associated with early redemption of the senior unsecured notes due May 2027 and partial early redemption of the senior unsecured notes due November 2028.

Current wording

For the nine months ended September 30, 2026, we recognized a loss on extinguishments of debt of $11 million related to the partial early redemptions of the senior secured Euro term loan due August 2028, along with costs associated with early redemption of the senior unsecured notes due May 2027 and partial early redemption of the senior unsecured notes due November 2028.

Previous wording

As a result of the Company’s 2026 debt-related activity, anticipated annual interest expense is expected to decrease approximately $1 million. This expected annual interest expense reduction reflects the positive impact of repayments of the senior unsecured notes due May 2027, partial repayment of the senior unsecured notes due November 2028, pay down of a portion of the outstanding tranche B-3 euro term loan due August 2028, and the cross-currency swap of the senior unsecured notes, partially offset by the issuance of the 2034 Notes in March 2026. For further details, see “Note 15 – Debt” and "Note 20 - Financial Instruments" to the Interim Consolidated Financial Statements.

Current wording

As a result of the Company’s 2026 debt-related activity, anticipated annual interest expense is expected to decrease approximately $3 million. This expected annual interest expense reduction reflects the positive impact of repayments of the senior unsecured notes due May 2027, partial repayment of the senior unsecured notes due November 2028, pay down of a portion of the outstanding tranche B-3 euro term loan due August 2028, and the cross-currency swap of the senior unsecured notes, partially offset by the issuance of the 2034 Notes in March 2026. For further details, see “Note 15 – Debt” and "Note 20 - Financial Instruments" to the Interim Consolidated Financial Statements.

Previous wording

A substantial majority of the $516 million of unrestricted cash and cash equivalents held by our foreign subsidiaries at June 30, 2026, is available for local operations or is readily convertible into currencies used in our worldwide operations, including the U.S. dollar. We are subject to restrictions imposed by the local governments in certain jurisdictions where we operate, which impose certain limitations on our ability to exchange currencies, repatriate earnings or capital, or create cross-border cash pooling arrangements. During the six months ended June 30, 2026, we received approximately $578 million of net cash in the U.S. through intercompany loans and dividends. We believe we have the ability to fund U.S. operations cash requirements for working capital, dividends, investments, and other financing requirements through a mixture of repatriations, intercompany loans, and other actions. For further information related to our income tax positions, refer to “Note 9 – Income Taxes” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025.

Current wording

A substantial majority of the $410 million of unrestricted cash and cash equivalents held by our foreign subsidiaries at September 30, 2026, is available for local operations or is readily convertible into currencies used in our worldwide operations, including the U.S. dollar. We are subject to restrictions imposed by the local governments in certain jurisdictions where we operate, which impose certain limitations on our ability to exchange currencies, repatriate earnings or capital, or create cross-border cash pooling arrangements. During the nine months ended September 30, 2026, we received approximately $761 million of net cash in the U.S. through intercompany loans and dividends. We believe we have the ability to fund U.S. operations cash requirements for working capital, dividends, investments, and other financing requirements through a mixture of repatriations, intercompany loans, and other actions. For further information related to our income tax positions, refer to “Note 9 – Income Taxes” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025.

Previous wording

Environmental remediation– We, due to the terms of our Separation-related agreements with EID, are subject to contingencies pursuant to environmental laws and regulations that in the future may require further action to correct the effects on the environment of prior disposal practices or releases of chemical substances, which are attributable to EID’s activities before our spin-off. Much of this liability results from Comprehensive Environmental Response Compensation and Liability Act (“CERCLA”), Resource Conservation and Recovery Act (“RCRA”), and similar federal, state, local, and foreign laws. These laws may require us to undertake certain investigative, remediation, and restoration activities at sites where we conduct or EID once conducted operations or at sites where waste generated by us was disposed. At June 30, 2026, our consolidated balance sheets include $795 million for environmental remediation liabilities, of which $124 million was classified as current, and a portion is subject to recovery under the MOU. Of the current environmental liabilities of $124 million, $47 million relates to Fayetteville. Pursuant to the binding MOU that we entered into with DuPont, Corteva, and EID in January 2021, costs related to potential future legacy PFAS liabilities arising out of pre-July 1, 2015 conduct will subject to the cost-sharing arrangement, where we bear half of the cost of such future potential legacy PFAS liabilities and DuPont and Corteva will collectively bear the other half of the cost of such future potential legacy PFAS liabilities up to an aggregate $4 billion, of which approximately $1.3 billion is available after consideration of the funding of the payment to the State of Ohio, and supplemental payment to the State of Delaware, and the net present value of the scheduled settlement payments per the terms of the settlement agreement with the State of New Jersey, described further below. Any PFAS-related insurance recoveries, as received, will increase the future amount available under the MOU. The $1.3 billion available amount above does not include any potential future insurance proceeds not yet received under noticed insurance policies, which have policy limits that total $750 million. Refer to the “Environmental Matters” section within this MD&Afor the anticipated environmental remediation payments over the next three years. Refer to “Note 17 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements for further discussion of the MOU and Qualified Spend.

Current wording

Environmental remediation– We, due to the terms of our Separation-related agreements with EID, are subject to contingencies pursuant to environmental laws and regulations that in the future may require further action to correct the effects on the environment of prior disposal practices or releases of chemical substances, which are attributable to EID’s activities before our spin-off. Much of this liability results from Comprehensive Environmental Response Compensation and Liability Act (“CERCLA”), Resource Conservation and Recovery Act (“RCRA”), and similar federal, state, local, and foreign laws. These laws may require us to undertake certain investigative, remediation, and restoration activities at sites where we conduct or EID once conducted operations or at sites where waste generated by us was disposed. At September 30, 2026, our consolidated balance sheets include $805 million for environmental remediation liabilities, of which $116 million was classified as current, and a portion is subject to recovery under the MOU. Of the current environmental liabilities of $116 million, $47 million relates to Fayetteville. Pursuant to the binding MOU that we entered into with DuPont, Corteva, and EID in January 2021, costs related to potential future legacy PFAS liabilities arising out of pre-July 1, 2015 conduct will be subject to the cost-sharing arrangement, where we bear half of the cost of such future potential legacy PFAS liabilities and DuPont and Corteva will collectively bear the other half of the cost of such future potential legacy PFAS liabilities up to an aggregate $4 billion, of which approximately $1.1 billion is available after consideration for PFAS-related insurance recoveries and the net present value of the scheduled settlement payments per the terms of the settlement agreement with the State of New Jersey, and the net present value, as agreed to with DuPont and Corteva of the North Carolina settlement payments, described further below. Any PFAS-related insurance recoveries, as received, increase the amount available under the MOU. The $1.1 billion available amount above reflects $170 million recovered to date but does not include any potential future insurance proceeds not yet received under noticed insurance policies, which have remaining policy limits that total $625 million. Refer to the “Environmental Matters” section within this MD&Afor the anticipated environmental remediation payments over the next three years. Refer to “Note 17 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements for further discussion of the MOU and Qualified Spend.

Previous wording

PFAS escrow funding requirements– Pursuant to the binding MOU that we entered into with DuPont, Corteva, and EID in January 2021, the parties have agreed to establish an escrow account in order to support and manage the payments for potential future legacy PFAS liabilities. In September 2023, we entered into a supplemental agreement to the binding MOU with DuPont, Corteva, and EID, whereby the parties agreed to i) release funds held in escrow to fund, in part, the qualified settlement fund per the terms of the U.S. public water system settlement agreement, ii) waive the escrow funding obligation of each party due no later than September 30, 2023 and iii) waive the escrow funding obligation due no later than September 30, 2024 under certain conditions as agreed to by the parties. The parties agreed to fund the payments due by September 30, 2024, and we funded $50 million into the escrow account on September 30, 2024. Pursuant to the terms of the PFAS Insurance Proceeds Memorandum of Understanding ("PFAS Insurance MOU"), the parties agreed to suspend the obligation of each of the parties to fund the $50 million MOU payments due by September 30, 2025. Additionally, also pursuant to the terms of the PFAS Insurance MOU, the parties agreed that our future MOU funding requirements will be reduced by amounts released from the insurance proceeds escrow to fund the New Jersey settlement. The next escrow payment of $50 million is currently due on or before September 30, 2026 and the following payments are expected on or before September 30 of each subsequent year through and including 2028. As such, at June 30, 2026 and December 31, 2025, we had $50 million deposited into the escrow account. If on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, the balance of the escrow is to be restored to such amount, with Chemours making 50% of the deposits and DuPont and Corteva together making 50% of the deposits. Such payments will be made in a series of five consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU. The parties will cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU, including, as applicable, potential additional agreements to facilitate certain ongoing mediation or settlement discussions. Refer to “Note 17 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statementsfor further discussion.

Current wording

PFAS escrow funding requirements– Pursuant to the binding MOU that we entered into with DuPont, Corteva, and EID in January 2021, the parties have agreed to establish an escrow account in order to support and manage the payments for potential future legacy PFAS liabilities. In September 2023, we entered into a supplemental agreement to the binding MOU with DuPont, Corteva, and EID, whereby the parties agreed to i) release funds held in escrow to fund, in part, the qualified settlement fund per the terms of the U.S. public water system settlement agreement, ii) waive the escrow funding obligation of each party due no later than September 30, 2023 and iii) waive the escrow funding obligation due no later than September 30, 2024 under certain conditions as agreed to by the parties. The parties agreed to fund the payments due by September 30, 2024, and we funded $50 million into the escrow account on September 30, 2024. Pursuant to the terms of the PFAS Insurance Proceeds Memorandum of Understanding ("PFAS Insurance MOU"), the parties agreed to suspend the obligation of each of the parties to fund the $50 million MOU payments due by September 30, 2025. Additionally, also pursuant to the terms of the PFAS Insurance MOU, the parties agreed that future MOU funding requirements will be reduced by amounts released from the insurance proceeds escrow to fund the New Jersey settlement. As a result of the North Carolina settlement reached and further understanding between the Company, DuPont, Corteva, and EID, all future contributions to the MOU escrow account are considered satisfied by the companies’ New Jersey and North Carolina settlement payments, including the $50 million escrow contribution that would have been due in September 2026. The Company used $50 million of restricted cash to fund part of the first New Jersey annual settlement payment during the three months ended September 30, 2026. As of September 30, 2026 and December 31, 2025, the Company had $3 million and $52 million in the MOU escrow account, inclusive of interest, respectively, which is recognized as restricted cash and restricted cash equivalents on its consolidated balance sheets. The parties will cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU, including, as applicable, potential additional agreements to facilitate certain ongoing mediation or settlement discussions. Refer to “Note 17 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statementsfor further discussion.

Previous wording

Other legal settlements- In addition to the legal items noted above, we have other legal settlements that we expect to pay within the next 12 months and beyond. In November 2023, we, DuPont, Corteva, and EID entered into a settlement agreement with the State of Ohio to settle claims, including for environmental releases or sales of products containing PFAS or other known contaminants. Our share of this settlement was $45 million that was paid to the state in November 2025, and the remaining share of $10 million, was paid in April 2026, which represented our portion of the contribution consistent with the MOU entered into among the parties in January 2021. Following the settlement agreement with the State of Ohio and pursuant to the terms of the settlement agreement with the State of Delaware entered into in 2021, in January 2026, we contributed our portion of the supplemental payment to the State of Delaware for $13 million. In June 2025, EID and Chemours reached an agreement in principle to resolve the Hoosick Falls class action lawsuit. Our portion of the total settlement in accordance with the MOU is $13.5 million, of which, $11 million was paid in July 2026, and the remaining $2.5 million paid in five installments annually. In August 2025, Chemours, Chemours FC LLC, Corteva, EID, DuPont and DuPont Specialty Products (collectively, “the NJ Settling Companies”), and the State of New Jersey agreed to a Judicial Consent Order (“JCO”) on terms consistent with the recommended settlement agreement. Under the JCO, the Companies will make scheduled annual settlement payments totaling $875 million over a 25-year period. Our portion of the scheduled annual settlement payments is $269 million as of June 30, 2026 on a net present value basis. We expect that the $150 million consideration pursuant to the PFAS Insurance MOU as well as the $50 million restricted cash in the MOU escrow account will fully fund our New Jersey settlement payment obligations through at least 2030. In June 2026 we entered into an agreement with EPA, as well as the WVDEP, whereas we are expected to pay the EPA and WVDEP a $23 million civil penalty over a three-year period. We have accrued litigation of $658 million at June 30, 2026, of which $357 million is classified as current. Refer to “Note 17 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statementsfor further discussion.

Current wording

Other legal settlements- In addition to the legal items noted above, we have other legal settlements that we expect to pay within the next 12 months and beyond. In November 2023, we, DuPont, Corteva, and EID entered into a settlement agreement with the State of Ohio to settle claims, including for environmental releases or sales of products containing PFAS or other known contaminants. Our share of this settlement was $45 million that was paid to the state in November 2025, and the remaining share of $10 million, was paid in April 2026, which represented our portion of the contribution consistent with the MOU entered into among the parties in January 2021. Following the settlement agreement with the State of Ohio and pursuant to the terms of the settlement agreement with the State of Delaware entered into in 2021, in January 2026, we contributed our portion of the supplemental payment to the State of Delaware for $13 million. In June 2025, EID and Chemours reached an agreement in principle to resolve the Hoosick Falls class action lawsuit. Our portion of the total settlement in accordance with the MOU is $13.5 million, of which, $11 million was paid in July 2026, and the remaining $2.5 million to be paid in five annual installments. In August 2025, Chemours, Chemours FC LLC, Corteva, EID, DuPont and DuPont Specialty Products (collectively, “the NJ Settling Companies”), and the State of New Jersey agreed to a Judicial Consent Order (“JCO”) on terms consistent with the recommended settlement agreement. Under the JCO, the Companies will make scheduled annual settlement payments totaling $875 million over a 25-year period. Following the first $100 million payment made in September 2026, our portion of the remaining scheduled annual settlement payments is $176 million as of September 30, 2026 on a net present value basis. In addition, concurrent with the JCO being finalized, the PFAS Insurance MOU with Corteva and DuPont was enacted. This resulted in Corteva and DuPont funding $150 million into an escrow account for the restricted purpose of funding the Company’s future New Jersey annual settlement payments. We expect that the remaining restricted cash received pursuant to the PFAS Insurance MOU will fully fund our New Jersey annual settlement payment obligations through at least 2030. In June 2026 we entered into an agreement with EPA, as well as the WVDEP, whereas we are expected to pay the EPA and WVDEP a $23 million civil penalty over a three-year period. We have accrued litigation of $553 million at September 30, 2026, of which $191 million is classified as current. Refer to “Note 17 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statementsfor further discussion.

Previous wording

We continue to believe our sources of liquidity are sufficient to fund our planned operations and to meet our principal, interest, dividend, income taxes, and contractual obligations through at least the end of August 2027. Our capital allocation strategy is aligned with our strategic priorities under Pathway to Thrive and commitment to balance sheet flexibility. Our capital allocation strategy seeks to (i) focus investments in growth initiatives to enhance our portfolio; (ii) improve our leverage profile; (iii) responsibly resolve contingent legal and/or accrued environmental liabilities on terms and bases deemed to be in the best interest of the Company and its stakeholders; and (iv) return cash to shareholders through regular quarterly dividends. Since its inception, the Company has consistently maintained a long practice of returning capital to its shareholders, which will remain a strategic priority going forward. On August 4, 2026, the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the second quarter of 2026. The dividend will be paid on September 15, 2026, to stockholders of record as of August 14, 2026.

Current wording

We continue to believe our sources of liquidity are sufficient to fund our planned operations and to meet our principal, interest, dividend, income taxes, and contractual obligations through at least the end of November 2027. Our capital allocation strategy is aligned with our strategic priorities under Pathway to Thrive and commitment to balance sheet flexibility. Our capital allocation strategy seeks to (i) focus investments in growth initiatives to enhance our portfolio; (ii) improve our leverage profile; (iii) responsibly resolve contingent legal and/or accrued environmental liabilities on terms and bases deemed to be in the best interest of the Company and its stakeholders; and (iv) return cash to shareholders through regular quarterly dividends. Since its inception, the Company has consistently maintained a long practice of returning capital to its shareholders, which will remain a strategic priority going forward. On October 27, 2026, the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2026. The dividend will be paid on December 15, 2026, to stockholders of record as of November 16, 2026.

Previous wording

The following table sets forth a summary of the net cash provided by (used for) our operating, investing, and financing activities for the six months ended June 30, 2026 and 2025.

Current wording

The following table sets forth a summary of the net cash provided by (used for) our operating, investing, and financing activities for the nine months ended September 30, 2026 and 2025.

Previous wording

We generated $114 million in cash flows for our operating activities during the six months ended June 30, 2026. Comparatively, we used $19 million in cash flows for our operating activities during the six months ended June 30, 2025. The increase in our operating cash inflows was primarily attributable to changes in net working capital as a result of fewer inventory purchases made in 2026, in addition to higher earnings in the second quarter of 2026.

Current wording

We generated $263 million in cash flows for our operating activities during the nine months ended September 30, 2026. Comparatively, we generated $127 million in cash flows for our operating activities during the nine months ended September 30, 2025. The increase in our operating cash inflows was primarily attributable to a reduced inventory balance as a result of our effort to optimize inventory levels and performance, timing of payments, as we paid for 2024 year-end plant turnaround activities and capital expenditure projects in 2025, and a cash inflow related to the PFAS Insurance MOU, net of the first annual New Jersey settlement payment in 2026.

Previous wording

We generated $195 million in cash flows for our investing activities during the six months ended June 30, 2026. Comparatively, we used $128 million in cash flows for our investing activities during the six months ended June 30, 2025. The increase in our investing cash inflows was primarily attributable to $294 million in proceeds from sales of assets and business, primarily due to the net proceeds of the Kuan Yin land sale. This cash generation was partially offset by purchases of property, plant, and equipment of $93 million during the six months ended June 30, 2026, compared to $127 million for the six months ended June 30, 2025. The decrease in cash spending related to property, plant, and equipment is due to timing of payments, as there were more payments in 2025, partially offset by increased capital project spend incurred year-over-year.

Current wording

We generated $188 million in cash flows for our investing activities during the nine months ended September 30, 2026. Comparatively, we used $163 million in cash flows for our investing activities during the nine months ended September 30, 2025. The increase in our investing cash inflows was primarily attributable to $342 million in proceeds from sales of assets and business, primarily due to the net proceeds of the Kuan Yin land sale. This cash generation was partially offset by purchases of property, plant, and equipment of $144 million during the nine months ended September 30, 2026, compared to $168 million for the nine months ended September 30, 2025. The decrease in cash spending related to property, plant, and equipment is due to timing of payments, as there were more payments in 2025, partially offset by increased capital project spend incurred year-over-year.